Technical Analysis for RXMD - Progressive Care

Grade Last Price % Change Price Change
grade D 0.043 -4.44% -0.0020
RXMD closed down 4.44 percent on Thursday, August 22, 2019, on 8.44 times normal volume. The bears made the stock sink to a new 52-week low.

Trend Table & Recent Signals
ADX Long-Term Intermediate-Term Short-Term
Strong Down Down Down
See historical RXMD trend table...

Date Alert Name Type % Chg
New 52 Week Closing Low Bearish 0.00%
Expansion Breakdown Bearish Swing Setup 0.00%
Reversal New Lows Setup Bearish Swing Setup 0.00%
Volume Surge Other 0.00%
Wide Range Bar Range Expansion 0.00%
Doji - Bullish? Reversal 0.00%
New 52 Week Low Weakness 0.00%
Outside Day Range Expansion 0.00%
Wide Bands Range Expansion 0.00%
Below Lower BB Weakness 0.00%

Older signals for RXMD ...

Get a Trading Assistant

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:
Profile
Progressive Care, through its subsidiary PharmCo, LLC, provides prescription pharmaceuticals, specializing in health practice risk management, compounded medications, the sale of anti-retroviral medications and related medication therapy management, and the supply of prescription medications to long term care facilities. The Company also provides 340B services to community organizations, patient health risk reviews, free same-day delivery and serves as a case management access point.As a specialty pharmacy catering to the needs of patients in need of anti-retroviral medications, and to increase the quality and credibility of the services we provide to these patients, the Company has a staff that is well trained in acute illnesses. Further, the Company provides confidential prescription packaging that suits the individual patient?s needs and lifestyle.Pharmco?s compounding department specializes in formularies such as non-narcotic topical pain creams, wound care creams, scar gels and hormone replacement therapies. The company also offers EnovaRx, which are FDA approved manufactured pain creams that are readily available with a prescription. In addition to these medications, Pharmco prepares psoriasis creams, wellness vitamins, weight loss formulations and holistic capsules which are 100% Kosher and Halal certified. Compounded medications require strict compliance procedures and are highly labor intensive. As such, these medications can carry significantly higher gross margins than traditional mass manufactured prescriptions. The Company believes that diversifying into this area of the pharmaceutical industry will be greatly beneficial to both its short term financial position as well as its long term viability in the market.For its long term care customers, PharmCo provides purchasing, repackaging and dispensing of both prescription and non-prescription pharmaceutical products. PharmCo utilizes a unit-of-dose packaging system as opposed to the traditional vials used for its retail customers. This method of distribution improves control and patient compliance with recommended drug therapy by increasing the timeliness and accuracy of medication dispensing. PharmCo also provides computerized maintenance of patient prescription histories, third party billing and consultant pharmacist services. Its consulting services consist primarily of evaluation of monthly patient drug therapy and monitoring the institution's drug distribution system.The Company has begun receiving revenue from its work in Medication Therapy Management (MTM). MTM involves review and adjustment of prescribed drug therapies to improve patient health outcomes. This process includes a number of activities such as performing patient assessments, creating medication treatment plans, monitoring the effectiveness of and adherence to prescribed therapies and delivering documentation of these services to the patient's physician to coordinate comprehensive care.Progressive Care, Inc. is headquartered in North Miami Beach, Florida.
Health Pharmaceutical Industry Pharmacy Retail Customers Fda Medical Prescription Clinical Pharmacology Psoriasis Prescription Drug Compounding Drug Therapies Pharmacist Adherence Prescription Pharmaceuticals Drug Therapy Hormone Replacement Therapies Specialty Drugs In The United States
Is RXMD a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 0 bullish, 4 bearish and 1 neutral indicators. You may wish to incorporate that into your trading strategies.
Indicators
Indicator Value
52 Week High 0.0915
52 Week Low 0.03
Average Volume 515,509
200-Day Moving Average 0.0624
50-Day Moving Average 0.0591
20-Day Moving Average 0.0537
10-Day Moving Average 0.0511
Average True Range 0.0062
ADX 40.05
+DI 5.711
-DI 36.014
Chandelier Exit (Long, 3 ATRs ) 0.0434
Chandelier Exit (Short, 3 ATRs ) 0.0486
Upper Bollinger Band 0.0643
Lower Bollinger Band 0.0431
Percent B (%b) 0.0
BandWidth 39.478585
MACD Line -0.0035
MACD Signal Line -0.0026
MACD Histogram -0.0009
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 0.0760
Resistance 3 (R3) 0.0753 0.0637 0.0705
Resistance 2 (R2) 0.0637 0.0553 0.0640 0.0687
Resistance 1 (R1) 0.0533 0.0501 0.0475 0.0540 0.0668
Pivot Point 0.0417 0.0417 0.0388 0.0420 0.0417
Support 1 (S1) 0.0313 0.0333 0.0255 0.0320 0.0192
Support 2 (S2) 0.0197 0.0281 0.0200 0.0173
Support 3 (S3) 0.0093 0.0197 0.0155
Support 4 (S4) 0.0100